The present invention relates to a stable liquid pharmaceutical composition of phosphocreatine, or a pharmaceutically alkaline salt thereof useful in the treatment of cardiac and skeleton muscle protection in heart surgery, in cardiology area and in rehabilitation. The present invention also provides a process for the preparation of the liquid composition of phosphocreatine, or a pharmaceutically acceptable alkaline salt thereof.